Original Research

Published on 21 Jul 2023

Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study

in Pharmacology of Anti-Cancer Drugs

Daling Dong
Shixin Zhang
Bin Jiang
Wei Wei
Chao Wang
Qian Yang
Tingzhi Yan
Min Chen
Liken Zheng
Weikang Shao

Frontiers in Oncology

doi 10.3389/fonc.2023.1222716

3,002 views
2 citations

Systematic Review

Published on 20 Jul 2023

Efficacy and safety of metformin in combination with chemotherapy in cancer patients without diabetes: systematic review and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Kang Yang
Hao-hao Lu
Wei Zhao
Qingchun Zhao

Frontiers in Oncology

doi 10.3389/fonc.2023.1176885

1,851 views
4 citations

Editorial

Published on 20 Jul 2023

Editorial: Anti-cancer drug delivery: lipid-based nanoparticles

in Pharmacology of Anti-Cancer Drugs

Alaaldin M. Alkilany
Abdelbary Elhissi
Walhan Alshaer
Amit Kunwar
Jyotsnendu Giri

Frontiers in Oncology

doi 10.3389/fonc.2023.1248272

1,765 views
1 citation

Original Research

Published on 18 Jul 2023

Effect of four fluoroquinolones on the viability of bladder cancer cells in 2D and 3D cultures

in Pharmacology of Anti-Cancer Drugs

Tomasz Kloskowski
Zuzanna Fekner
Kamil Szeliski
Michelle Paradowska
Daria Balcerczyk
Marta Rasmus
Paweł Dąbrowski
Łukasz Kaźmierski
Tomasz Drewa
Marta Pokrywczyńska

Frontiers in Oncology

doi 10.3389/fonc.2023.1222411

2,443 views
3 citations

Review

Published on 14 Jul 2023

A literature review on the impact of disasters on healthcare systems, the role of nursing in disaster management, and strategies for cancer care delivery in disaster-affected populations

in Pharmacology of Anti-Cancer Drugs

Wen Wang
Hui Li
Miao Huang

Frontiers in Oncology

doi 10.3389/fonc.2023.1178092

6,057 views
5 citations

Original Research

Published on 11 Jul 2023

PIWIL1 interacting RNA piR-017724 inhibits proliferation, invasion, and migration, and inhibits the development of HCC by silencing PLIN3

in Pharmacology of Anti-Cancer Drugs

Yi-Jing Wu
Jie Wang
Peng Zhang
Liu-Xia Yuan
Lin-Ling Ju
Hui-Xuan Wang
Lin Chen
Ya-Li Cao
Wei-Hua Cai
Yi Ni

Frontiers in Oncology

doi 10.3389/fonc.2023.1203821

1,906 views
6 citations

Review

Published on 10 Jul 2023

Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens

in Pharmacology of Anti-Cancer Drugs

Nityanand Srivastava
Salman Sadullah Usmani
Rajasekaran Subbarayan
Rashmi Saini
Pranav Kumar Pandey

Frontiers in Oncology

doi 10.3389/fonc.2023.1199105

7,930 views
12 citations

Review

Published on 06 Jul 2023

Insight into lipid-based nanoplatform-mediated drug and gene delivery in neuro-oncology and their clinical prospects

in Pharmacology of Anti-Cancer Drugs

Manasa Manjunath Hegde
Puja Sandbhor
Aishwarya J.
Vikram Gota
Jayant S. Goda

Frontiers in Oncology

doi 10.3389/fonc.2023.1168454

2,657 views
2 citations

Review

Published on 04 Jul 2023

Malignant mesothelioma tumours: molecular pathogenesis, diagnosis, and therapies accompanying clinical studies

in Pharmacology of Anti-Cancer Drugs

Ram Kumar Sahu
Sakina Ruhi
Ashok Kumar Jeppu
Husni Ahmed Al-Goshae
Ayesha Syed
Sanjay Nagdev
Retno Widyowati
Wiwied Ekasari
Jiyauddin Khan
Bedanta Bhattacharjee

Frontiers in Oncology

doi 10.3389/fonc.2023.1204722

8,085 views
10 citations

Case Report

Published on 03 Jul 2023

Intravenous immunoglobulin is safe and effective in controlling pre-existing paraneoplastic neuromuscular diseases in cancer patients treated with immune checkpoint inhibitors: two case reports and literature review

in Pharmacology of Anti-Cancer Drugs

Ge Xiong
Richard Benjamin Young
Helen Chow
Emanual Maverakis
Ricardo A. Maselli
David Paul Richman
Tianhong Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1199195

3,139 views
2 citations

Case Report

Published on 30 Jun 2023

Case Report: Advanced pulmonary sarcomatoid carcinoma with adrenal gland metastasis after sintilimab combined with anlotinib treatment

in Pharmacology of Anti-Cancer Drugs

Gangyi Dai
Lang He
Qin Yan
Yamao Li
Yuandong Huang
Bin Li
Guoping Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1167516

2,419 views
4 citations

Editorial

Published on 26 Jun 2023

Editorial: Novel targeted drugs for indolent lymphoid malignancies

in Pharmacology of Anti-Cancer Drugs

Tadeusz Robak
Bartosz Puła
Iwona Hus

Frontiers in Oncology

doi 10.3389/fonc.2023.1224528

1,489 views

Editorial

Published on 20 Jun 2023

Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer, Volume II

in Pharmacology of Anti-Cancer Drugs

Weilong Zhong
Tao Sun

Frontiers in Oncology

doi 10.3389/fonc.2023.1218855

1,183 views
1 citation

Original Research

Published on 20 Jun 2023

Adjuvant composite cold atmospheric plasma therapy increases antitumoral effect of doxorubicin hydrochloride

in Pharmacology of Anti-Cancer Drugs

Volha Kniazeva
Dzmitry Tzerkovsky
Ömür Baysal
Alexander Kornev
Evgeny Roslyakov
Serhei Kostevitch

Frontiers in Oncology

doi 10.3389/fonc.2023.1171042

2,474 views
4 citations

Editorial

Published on 19 Jun 2023

Editorial: RNA recognition landscapes and anticancer drug targeting

in Pharmacology of Anti-Cancer Drugs

Erica Salvati
Anna Lewinska
Erik Dassi
Maciej Wnuk
Vito G. D’Agostino

Frontiers in Oncology

doi 10.3389/fonc.2023.1222883

947 views

Review

Published on 19 Jun 2023

Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma

in Pharmacology of Anti-Cancer Drugs

Yubo Xiang
Yingxin Yang
Jia Liu
Xu Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1219211

4,262 views
8 citations

Navigation group

Articles

Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study

Efficacy and safety of metformin in combination with chemotherapy in cancer patients without diabetes: systematic review and meta-analysis

Editorial: Anti-cancer drug delivery: lipid-based nanoparticles

Effect of four fluoroquinolones on the viability of bladder cancer cells in 2D and 3D cultures

A literature review on the impact of disasters on healthcare systems, the role of nursing in disaster management, and strategies for cancer care delivery in disaster-affected populations

PIWIL1 interacting RNA piR-017724 inhibits proliferation, invasion, and migration, and inhibits the development of HCC by silencing PLIN3

Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens

Insight into lipid-based nanoplatform-mediated drug and gene delivery in neuro-oncology and their clinical prospects

Malignant mesothelioma tumours: molecular pathogenesis, diagnosis, and therapies accompanying clinical studies

Intravenous immunoglobulin is safe and effective in controlling pre-existing paraneoplastic neuromuscular diseases in cancer patients treated with immune checkpoint inhibitors: two case reports and literature review

Case Report: Advanced pulmonary sarcomatoid carcinoma with adrenal gland metastasis after sintilimab combined with anlotinib treatment

Editorial: Novel targeted drugs for indolent lymphoid malignancies

Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer, Volume II

Adjuvant composite cold atmospheric plasma therapy increases antitumoral effect of doxorubicin hydrochloride

Editorial: RNA recognition landscapes and anticancer drug targeting

Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma